GI
MED icon

GAMMA Investing’s Medifast MED Stock Holding History

GAMMA Investing’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Sell
900
-142
-14% -$1.62K ﹤0.01% 3316
2026
Q2 		$11.1K Buy
1,042
+137
+15% +$1.58K ﹤0.01% 3157
2026
Q1 		$9.22K Buy
905
+346
+62% +$3.73K ﹤0.01% 3108
2025
Q4 		$5.97K Sell
559
-661
-54% -$7.91K ﹤0.01% 3207
2025
Q3 		$16.7K Buy
1,220
+896
+277% +$12.5K ﹤0.01% 2611
2025
Q2 		$4.55K Buy
324
+86
+36% +$1.13K ﹤0.01% 3163
2025
Q1 		$3.21K Buy
238
+141
+145% +$2.12K ﹤0.01% 3251
2024
Q4 		$1.71K Sell
97
-560
-85% -$10.4K ﹤0.01% 3272
2024
Q3 		$12.6K Sell
657
-179
-21% -$3.45K ﹤0.01% 2353
2024
Q2 		$18.2K Buy
836
+752
+895% +$20K ﹤0.01% 1913
2024
Q1 		$3.22K Buy
84
+56
+200% +$2.71K ﹤0.01% 2579
2023
Q4 		$1.53K Buy
+28
New +$1.95K ﹤0.01% 2663

Other funds holding MED

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $155M AUM 15.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's MED Position: Q3 2026 in Review

GAMMA Investing reduced its Medifast (MED) stake by 14% in Q3 2026, selling an estimated $1.62K and leaving 900 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

GAMMA Investing first reported a position in MED in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.2K in Q2 2024. 4 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • GAMMA Investing held 900 shares of Medifast worth $10.4K as of Q3 2026.
  • GAMMA Investing sold 142 Medifast shares in Q3 2026, an estimated $1.62K.
  • Medifast made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3316 holding.
  • GAMMA Investing first reported a position in Medifast in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Medifast position peaked at $18.2K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.